Текст сохранён. Часть иллюстраций пока доступна только в первоисточнике; загрузка будет проверена повторно.
Introduction
Acute myeloid leukemia (AML) is a fatal hematological malignancy with high recurrence rate. For patients receiving the most intensive treatment, the overall 5-year survival rate remains below 50%. For the remaining patients, the prognosis is even worse ( Burnett, Wetzler & Lowenberg, 2011 ). AML is characterized by multiple recurring mutations. These mutations affect disease response to treatment and the risk of recurrence ( Patel et al., 2012 ; Short, Rytting & Cortes, 2018 ; Staudt et al., 2018 ; Xie et al., 2014 ). P62 regulates cell survival and death via various signal transduction pathways ( Komatsu, Kageyama & Ichimura, 2012 ). A study found that upregulated p62 expression could promote AML cell maturation into granulocytes, depending on NF-κB activation, predicting poor AML prognosis ( Trocoli et al., 2014 ). In addition, loss of p62 impaired leukemia cell growth and colony formation and prolonged the development of leukemia in mice ( Nguyen et al., 2019 ). High expression of the selective autophagy receptor p62 is associated with a poor prognosis in AML ( Nguyen et al., 2019 ).
Exosomes are nanometer-scale extracellular vesicles containing many microRNAs (miRNAs) that are secreted from cells in both normal and pathological conditions ( Skog et al., 2008 ). It has been found that normal hematopoietic stem cell proliferation and differentiation are suppressed by exosomes releasing miR-150 and miR-155 through c-MYB inhibition. In this manner, a malignant phenotype constitutes perpetual existence by changing hematopoietic stem cell biological behaviors ( Hornick et al., 2016 ). This finding suggests a biological role for such miRNAs in malignant tumor progression ( De Kouchkovsky & Abdul-Hay, 2016 ). Leukemic cells can stimulate neovascularization in the bone marrow ( Wang et al., 2019 ) and secrete angiogenic factors, indicating adverse prognosis in AML ( Haouas, 2014 ). Exosomes may accelerate angiogenesis and promote tumor progression by harboring miRNAs ( Aslan et al., 2019 ). Thus, exosomal miRNAs may be new targets for AML treatment. However, regulation of angiogenesis by p62 remains largely unknown.
In this study, we constructed a miRCURYTM LNA Array (v.19.0) of miRNAs in exosomes derived from AML cells after p62 knockdown. The miRNAs in exosomes were analyzed by identifying signature miRNAs. We then investigated angiogenesis in human umbilical vein endothelial cells (HUVECs) exposed to exosomes derived from parental U937 cells, p62-knockdown U937 cells, or control cells. The data from these studies may shed light on the relationship between exosomal miRNAs and AML, further enhancing our understanding of AML progression.Our study may aid the development of potential biomarkers for the diagnosis and prognosis of AML progression.
Materials and Methods
Cell culture and lentiviral vector cell line construction
The human acute monocytic leukemia cell line U937 was purchased from the Bena Culture Collection (Beijing, China) and stored in our laboratory. A recombinant lentivirus vector-mediated SQSTM1 gene (LV-SQSTM1-RNAi) and an empty recombinant adenovirus vector (Hu6-MCS-CMV-EGFP) were constructed. U937 cells were placed in a six-well plate. Polybrene (Gene, Shanghai, China) was used for the transfection. The transfection system included 1.8 mL RPMI-1640 with 10% fetal bovine serum, 10 µL LV-SQSTM1-RNAi or Hu6-MCS-CMV-EGFP, and 0.9 µL polybrene. After transfection for 24 h, the cell suspension was collected and centrifuged at 800 rpm for 5 min, the supernatant was discarded, and two mL of RPMI-1640 with 10% fetal bovine serum was added. After transfection for 48 h, fluorescence was observed. After culturing, 5 µg/mL puromycin was added, and the cells were screened for 15 days. After selecting the surviving cells, cell lines with clonal stability were cryopreserved and characterized through RT–qPCR and western blotting.
Cell viability cell counting kit (CCK)-8
U937 cells were plated at a density of 3–5 × 10 4 cells/well in 96-well plates and allowed to grow for 12, 24, and 48 h. Next, 10 µL CCK-8 solution (Promega, Madison, WI, USA) was added to the cell suspension and incubated for 2 h. Absorbance was measured using a spectrophotometer at 450 nm. The experiment was repeated at least three times.
Flow cytometric cell apoptosis
Flow cytometry analysis using an Annexin V-FITC/PI detection kit was used to compare the apoptosis rate of p62-control and p62 knockdown U937 cells. After 48 h of incubation, the cells were washed with phosphate-buffered saline and resuspended in 400 µL of 1 × binding buffer. Thereafter, 5 µL Annexin V-FITC and 5 µL PI were added to the mixture and stained in the dark for 15 min at room temperature. Apoptosis was detected using flow cytometry (Beckman Coulter, La Brea, CA, USA) immediately after staining.
Exosome collection and identification
P62-siRNA coated with lentivirus interfered with U937 cells to downregulate the expression of p62, with the empty virus vector used as a control. Two groups of cells were used as follows: p62-knockdown U937 cells and controls. The two groups of cells were cultured for 48 h in serum-free media. The supernatant was collected for exosome extraction via ultracentrifugation. Exosome shape and size were observed using electron microscopy, and exosomal markers were detected using western blot analysis.
Western blot analysis
Total protein was extracted from U937 cells that had or had not been transfected with the p62-encoding gene using radioimmunoprecipitation assay lysis buffer (Beyotime, Shanghai, China). The protein concentration was determined using the BCA method. Equal amounts of protein samples were added to each well, separated using 10% SDS-PAGE, and transferred to a polyvinylidene chloride transfer membrane (Merck Millipore, Burlington, MA, USA). The membrane was blocked with 5% skimmed milk for 2 h. It was then washed with TBST and incubated with primary antibodies against p62, TSG101, CD63, CD9, calnexin, and GAPDH (all from Abcam, Cambridge, UK; 1:1000) overnight at 4 °C. Thereafter, the membrane was incubated with anti-rabbit or anti-mouse horseradish peroxidase-conjugated secondary antibodies at room temperature for 2 h after washing three times with TBST. An enhanced chemiluminescence substrate (Thermo Fisher Scientific) was used to detect the protein bands. Image Lab software was used to detect and analyze the density of each band (Bio-Rad, Hercules, CA, USA).
RNA extraction, miRNA labeling and array hybridization
TRIzol (Invitrogen, Carlsbad, CA, USA) was used to extract total RNA. A NanoDrop spectrophotometer (ND-1000; NanoDrop Technologies, Wilmington, DE, USA) was used to measure RNA quality and quantity. RNA integrity was assessed using gel electrophoresis. After quality control, miRNA labeling was performed according to the instructions of the miRCURY™ Hy3™/Hy5™ Power Labeling Kit (Exiqon, Vedbaek, Denmark). First, 1 µL RNA in 2 µL water was mixed with 1 µL CIP buffer and CIP (Exiqon, Vedbaek, Denmark). The mixture was then incubated at 37 °C for 30 min. The mixture was incubated at 95 °C for 5 min to stop the reaction. Then, 3 µL labeling buffer, 1.5 µL fluorescent label (Hy3TM), 2 µL dimethyl sulfoxide, and 2 µL labeling enzyme were added. The mixture was then incubated for 1 h at 16 °C, followed by 15 min at 65 °C to terminate the reaction. Hy3-labeled samples were hybridized on the miRCURYTM LNA array (v.19.0; Exiqon, Vedbaek, Denmark) according to the manufacturer’s instructions. A total of 25 µL Hy3™-labeled samples and 25 µL hybridization buffer were denatured at 95 °C for 2 min and then incubated on ice for 2 min. The hybridization system (Nimblegen Systems, Inc., Madison, WI, USA) was used with the microarray set at 56 °C for 16 to 20 h. After hybridization, the slides were washed several times using a washing buffer kit (Exiqon, Vedbaek, Denmark). Finally, an Axon GenePix 4000 B microarray scanner (Axon Instruments, Foster City, CA, USA) was used to scan the slides.
miRNA array scanning and analysis
GenePix Pro 6.0 software (Axon, Instruments, Foster City, CA, USA) was used to extract data by analyzing the imported scanned images. The samples were chosen to calculate normalization factors if the replicated miRNAs were averaged and for miRNAs with intensities ≥30. Median normalization was used to normalize the data. Normalized data = (foreground background)/median; the median was the 50% quantile of miRNA intensity, which was larger than 30 in all samples after background correction. After normalization, the miRNAs with significant differences between the two groups were determined according to the fold change and P value. Finally, hierarchical clustering was used to show the different miRNA expression profiles between the samples.
MiRNA and mRNA networks and prediction of miRNA function
TargetScan7.1 ( http://www.targetscan.org/ ) and mirdbV5 ( http://mirdb.org/ ) are online sites for miRNA target gene prediction ( Agarwal et al., 2015 ; Chen & Wang, 2020 ). In our research, we used two databases to predict the target genes of differentially expressed miRNAs: targetscan7.1 and mirdbV5.
Gene ontology (GO) and kyoto encyclopedia of genes and genomes (KEGG) pathway analyses of differentially expressed miRNAs
We used the GO ( http://www.geneontology.org ) and KEGG ( http://www.genome.ad.jp/kegg/ ) databases to study the potential organisms and signaling pathways of differentially expressed miRNAs. Differences were considered statistically significant at P < 0.05.
Endothelial cell tube formation assays
HUVECs were exposed to exosomes derived from parental U937 cells, p62-knockdown U937 cells, or p62-control cells when cultured in 1640 medium. Cells were plated in 96-well plates with 50 µL Matrigel (BD Biosciences), seeded at 3 × 104 cells per well. Tubules were photographed using phase microscopy after incubation for 0, 3, and 6 h at 37 °C with 5% CO2.
Statistical analysis
We used GraphPad Prism 6 to corroborate the statistical significance of the data for all graphs in this study. Values are presented as the means ± standard deviation. Differences between groups were analyzed using Student’s t -test, and statistical significance was set at P < 0.05.
Results
Confirmation of knockdown p62 in U937 cell line
To generate p62-knockdown U937 cells, we used a lentivirus to transfect cells and observed the transfection efficiency by fluorescence microscopy. We then conducted RT–qPCR analysis to determine the expression levels of the autophagy gene encoding p62 ( Figs. 1A – 1B ) and western blotting to detect the expression levels of the autophagy core protein p62 ( Figs. 1C – 1D ). Notably, we found that the p62 gene and protein expression levels in U937 cells were successfully reduced compared with controls after LV-SQSTM1-RNAi treatment. CCK8 ( Fig. 1E ), and flow cytometry ( Figs. 1F – 1G ), show that p62 knockdown inhibits the proliferation of U-937 cells and promotes apoptosis.
Иллюстрация — в первоисточнике ↗
Characteristics of exosomes
We observed exosome formation using electron microscopy after ultracentrifugation. Electron microscopy revealed exosomes as vesicles with a double-layer membrane structure (30–100 nm in diameter, Fig. 2A ). Western blotting indicated that exosomes expressed TSG101, CD63, and CD9, but not calnexin ( Fig. 2B ). Exosome concentrations and quantities were measured using BCA. The concentrations of parental, control, and p62-knockdown U937 cells were 2.248 ± 0.245, 2.212 ± 0.092, and 2.189 ± 0.102, respectively ( Figs. 2C , 2D ). We found that the quantity of exosomes in p62-knockdown U937 cells was lower than that in the controls ( P < 0.05).
Иллюстрация — в первоисточнике ↗
Differentially expressed miRNAs in exosomes and PCR verification
We chose differentially expressed miRNAs in exosomes based on the fold change in the two samples. Microarray analysis revealed that 2,080 miRNAs were expressed in exosomes, 215 were upregulated, and 208 were downregulated (fold change ≥ 2, P < 0.05, Fig. 3A ) in p62-knockdown and control U937 cells. We found that miR-3064-3p, one of the top expressed miRNAs, and miR-339-5p, which was the most uniformly expressed endogenous control reference gene, were downregulated in U937 cells with p62 knockdown. RT–qPCR was used to detect the expression of exosomal miRNAs in the cells, revealing that the expression levels of miR-3064-3p and miR-339-5p decreased in U937 cells with p62 knockdown, consistent with the microarray profile ( Fig. 3B ).
Иллюстрация — в первоисточнике ↗
Иллюстрация — в первоисточнике ↗
Иллюстрация — в первоисточнике ↗
Иллюстрация — в первоисточнике ↗
GO and KEGG pathway analyses of differentially expressed miRNAs
We used GO and KEGG pathways to analyze the top 50 miRNAs that were upregulated and downregulated in p62-knockdown and control U937 cells, respectively. We focused on cellular component (CC) ( Figs. 4E – 4F ), biological process (BP) ( Figs. 4C – 4D ), and molecular function (MF) ( Figs. 4G – 4H ) targeted by upregulated and downregulated genes. We found that the neuron part was the top part of gene expression in downregulated genes, including 233 genes ( Fig. 4B ), and that the intercellular part was the top part of upregulated genes, including 1,843 genes ( Figs. 4G , 4E ). According to the BP analysis, 1,460 BPs were associated with downregulated transcripts, 19 pathways were related to vesicles, 1,515 pathways were related to upregulated transcripts, and 8 pathways were related to vesicles. MF analysis revealed that 1,544 upregulated genes and 1,200 downregulated genes were involved in protein binding ( Figs. 4G – 4H ). KEGG pathway analysis indicated that 84 pathways corresponded to upregulated transcripts, and 55 pathways corresponded to downregulated transcripts ( P < 0.05) ( Figs. 5A and 6A ). For downregulated transcripts, the “TNF signaling pathway” (Pathway ID: hsa04668) that included 23 genes was most affected, followed by the “MAPK pathway” (Pathway ID: hsa04010) ( Fig. 5A ). As for upregulated transcripts, the “PI3K–Akt signaling pathway” (Pathway ID: hsa04151) that included 80 upregulated genes was the most enriched pathway ( Fig. 6A ). The miRNAs of exosomes derived from U937 cells (p62-knockdown and controls) influenced gene expression and signaling pathways that participated in vesicle formation and AML generation ( Figs. 5A and 6A ).
MiRNA and mRNA networks and prediction of miRNA function
TargetScan7.1 ( http://www.targetscan.org/ ) and mirdbV5 ( http://mirdb.org/ ) were employed to predict the potential target genes of miRNAs. We found that 2,018 genes co-expressed with upregulated miRNAs and 2,749 genes co-expressed with downregulated miRNAs in the two databases ( Figs. 5B and 6B ). Besides, networks of miRNAs and mRNAs in upregulation and downregulation were shown in the Figs. 5C and 6C .
HUVEC angiogenesis
HUVECs were inoculated in Matrigel and incubated with AML exosomes for a certain period of time to determine whether exosomes from AML cells could induce HUVEC tubular differentiation in vitro . A CCK-8 assay was used to detect cell proliferation after 12, 24 and 48 h. The proliferation of cell lines was not statistically significant ( Fig. 7A ). Microscopic analysis showed that exosomes from U937 cells induced the formation of a tubular network, compared with p62-knockdown and p62-control cells ( Figs. 7B – 7C ). By counting the node number, junction number and segment length, we found that the HUVECs with U-937 cells and exosomes generated more blood vessels ( p < 0.05). Among the three groups of HUVECs+Exo(U937), HUVECs+Exo(p62-con) and HUVECs+Exo(p62-), the HUVECs+Exo(p62-) group grew slower than the other two groups ( p < 0.05). In summary, the above results indicated that the fastest angiogenesis occurred in the presence of exosomes from U937 cells; the slowest angiogenesis occurred in the presence of exosomes from p62-knockdown U937 cells.
Иллюстрация — в первоисточнике ↗
Discussion
Although advances have been made in AML supportive care, prognostic risk stratification, and established therapies, patients with AML have poor long-term prognosis ( De Kouchkovsky & Abdul-Hay, 2016 ). The identification of several gene mutations can guide treatment, such as PML-RARA for acute promyelocytic leukemia (APL). P62 is an autophagy receptor and a selective adaptor protein. In addition, p62 is involved in many signal transduction pathways, including the Keap1–Nrf2 pathway that plays a critical role in proteasomal degradation of ubiquitinated proteins and autophagy progression ( Liu et al., 2016 ). Ser407 of the ubiquitin-associated (UBA) domain of p62 is phosphorylated by autophagy-associated protein 1 (ATG1/ULK1), followed by phosphorylation at Ser403 of the UBA domain by casein kinase 2 or TANK-binding kinase 1 that leads to p62 ubiquitination and promotes autophagic degradation ( Myeku & Figueiredo-Pereira, 2011 ). The PB1 domain of p62 promotes packaging of ubiquitinated substrates by self-oligomerization and transports packaged substrates to the autophagy pathway to participate in autophagosome formation ( Ichimura et al., 2008 ). P62 interacts with LC3, an autophagosome marker protein, to form a complex through its LIR domain that is degraded in autophagosomes as an autophagy-specific substrate ( Pankiv et al., 2007 ). A study has shown that mutations in SQSTM1, which codes for p62, are a causative factor in Paget disease of bone, as well as amyotrophic lateral sclerosis and frontotemporal dementia ( Le Ber et al., 2013 ). Abnormal amplification and phosphorylation of p62/SQSTM1 have been implicated in tumor progression and resistance therapy, such as in hepatocellular carcinoma ( Saito et al., 2016 ), and platinum-resistant cells of high-grade serous ovarian cancer ( Nguyen et al., 2017 ). P62/SQSTM1 upregulation promotes granulocytic differentiation and survival of AML cells through a mechanism that depends on NF-κB activation ( Trocoli et al., 2014 ).
Accumulating evidence indicates that exosomes in tumors are oncogenic. Crosstalk between bone marrow tumors and endothelial cells can affect tumor progression in hematological tumors, and exosomes containing miRNAs are crucial in bone marrow angiogenesis promotion in hematological tumors. By delivering miR-365, exosomes can mediate the horizontal transfer of drug resistance in chronic myeloid leukemia cells ( Saito et al., 2016 ). K562 cells secrete exosomes containing miR-92a, which can enhance angiogenesis; miR-135b, which targets inhibitory hypoxia-inducible factor 1 angiogenesis, also enhances exocytosis secretion by multiple myeloma cells ( Ohyashiki, Umezu & Ohyashiki, 2016 ).
In our study, p62 knockdown in U937 cells inhibited cell proliferation and promoted apoptosis ( P < 0.05). We used microarray technology to study the expression patterns of exosomal miRNAs derived from two U937 cell lines to further explore the relationship between exosomal miRNAs and p62. We identified 2,080 miRNAs, including 215 upregulated and 208 downregulated miRNAs in p62-knockdown U937 cells. To further validate microarray analysis results, we performed RT–qPCR to validate the downregulated expression of miR-3064-3p and miR-339-5p in the same series of samples. Our future studies will involve identification of other miRNAs whose expression was the highest in our microarray results. The RT–qPCR results were consistent with those obtained from microarray analysis. In addition, KEGG pathway analysis revealed that 84 pathways corresponded to upregulated transcripts, and 55 pathways corresponded to downregulated transcripts. For the downregulated transcripts, the most affected pathway was the “TNF signaling pathway” (Pathway ID: hsa04668), followed by the “MAPK pathway” (Pathway ID: hsa04010). As for upregulated transcripts, the “PI3K–Akt signaling pathway” (Pathway ID: hsa04151) was the most enriched pathway.
We constructed a miRNA–mRNA correlation network that displayed 2,749 upregulated and 2,018 downregulated co-expressed genes in two databases. According to previous research, vascular endothelial growth factor A (VEGFA), VEGFC, GATA-binding protein 4 ( Jia et al., 2018 ), matrix metallopeptidase 2 ( Sun et al., 2010 ), and zinc finger protein ( Li et al., 2016 ), were involved in cell angiogenesis in the co-expression network. These results negatively correlated with those of hsa-miR-3064-3p and hsa-miR-339-5p in our profiles. Furthermore, hsa-miR-3622a-5p and hsa-miR-3064-3p displayed significant negative correlations with the Grb2-associated regulators of mitogen-activated protein kinase (MAPK) 1 and MAPK6, which participate in the MAPK signaling pathway. These findings indicate that hsa-miR-3064-3p, hsa-miR-339-5p, hsa-miR-3622a-5p, and their co-expressed coding genes in the MAPK signaling pathway may play a significant role in the angiogenesis of AML cells.
Although AML cells secrete angiogenic factors to remodel the vascular system and gain chemoresistance, anti-angiogenic drugs are generally ineffective in AML treatment. Wang et al. (2019) found that exosomes secreted by AML cells can enhance glycolysis-mediated vascular remodeling and chemoresistance. According to previous reports, wogonoside inhibits angiogenesis in solid tumors by blocking the JAK2-STAT3 pathway and inhibiting the development of hematologic malignancies in AML ( Lin et al., 2019 ). To further validate the exosome and angiogenesis results in AML, we grew HUVECs in the presence of exosomes derived from parental U937 cells, p62-knockdown U937 cells, and p62-control cells. We found that angiogenesis was fastest in the presence of U937 exosomes and slowest in the presence of p62-knockdown U937 exosomes. This finding illustrates that exosomes derived from AML cells play an important role in the angiogenesis of HUVECs.
Conclusions
In conclusion, after a detailed examination of miRNA expression in exosomes derived from AML cells, we found that hsa-miR-3064-3p and hsa-miR-339-5p displayed downregulated expression in p62-knockdown cells, compared with control cells. In addition, we demonstrated that several differentially expressed exosomal miRNAs were closely related to multiple GO items and pathways involved in carcinogenesis, indicating that exosomal miRNAs play a key role in AML pathogenesis. This information may aid the development of potential biomarkers for diagnosis and prognosis of AML progression. In the present study, we also found that exosomes derived from AML cells promoted angiogenesis. However, the relationship between exosomal miRNAs and angiogenesis needs to be further investigated. These findings support the notion that promising new treatment strategies may be developed against AML, based on exosomal miRNA analysis.
Supplemental Information
Raw data exported from the P62 transfection
Click here for additional data file.
Raw data exported from the lentiviral transfection
Click here for additional data file.
Raw data exported from the western blot in our experiment
Click here for additional data file.
Raw data exported from the exosome extraction
Click here for additional data file.
Raw data exported from the flow cytometry in apoptosis assay
Click here for additional data file.
Raw data exported from the sequencing analysis of miRNA
Click here for additional data file.
Raw data exported from the CCK-8 assay
Click here for additional data file.
Raw data exported from endothelial cell tube formation assays at 0h
Click here for additional data file.
Raw data exported from PCR and CCK-8 after P62 knockdown
Click here for additional data file.
The first experiment results of raw data exported from endothelial cell tube formation assays in HUVEC at 3h
Click here for additional data file.
The first experiment results of raw data exported from endothelial cell tube formation assays in control group at 3h
Click here for additional data file.
Raw data exported from endothelial cell tube formation assays in HUVEC at 3 h (the first experiment pictures)
Click here for additional data file.
Raw data exported from endothelial cell tube formation assays in control group at 3 h (the first experiment pictures)
Click here for additional data file.
raw data
Click here for additional data file.
The second experiment results of raw data exported from endothelial cell tube formation assays in control group at 3h
Click here for additional data file.
Raw data exported from endothelial cell tube formation assays in HUVEC at 3 h (the third experiment pictures)
Click here for additional data file.
Raw data exported from endothelial cell tube formation assays in HUVEC at 3 h (the second experiment pictures, repeat the first time)
Click here for additional data file.
Raw data exported from endothelial cell tube formation assays in HUVEC at 3 h (the first experiment pictures, repeat the second time)
Click here for additional data file.
The first experiment results of raw data exported from endothelial cell tube formation assays in p62 knockdown group at 3h
Click here for additional data file.
The fourth experiment results of raw data exported from endothelial cell tube formation assays in p62 knockdown group at 3h
Click here for additional data file.
Raw data exported from endothelial cell tube formation assays in control group at 3 h (the second experiment pictures, repeat the first time)
Click here for additional data file.
Raw data exported from endothelial cell tube formation assays in control group at 3 h (the third experiment pictures, repeat the first time)
Click here for additional data file.
The second experiment results of raw data exported from endothelial cell tube formation assays in p62 knockdown group at 3 h (repeat the first time)
Click here for additional data file.
Raw data exported from endothelial cell tube formation assays in control group at 3 h (the second experiment pictures)
Click here for additional data file.
Raw data exported from endothelial cell tube formation assays in U-937 at 3 h (the first experiment pictures, repeat the second time)
Click here for additional data file.
Raw data exported from endothelial cell tube formation assays in control group at 3 h (the third experiment pictures, repeat the first time)
Click here for additional data file.
Raw data exported from endothelial cell tube formation assays in p62 knockdown group at 3 h (the third experiment pictures, repeat the first time)
Click here for additional data file.
Raw data exported from endothelial cell tube formation assays in p62 knockdown group at 3 h (the first experiment pictures, repeat the first time)
Click here for additional data file.
Raw data exported from endothelial cell tube formation assays in p62 knockdown group at 3 h (the fourth experiment pictures, repeat the first time)
Click here for additional data file.
Raw data exported from endothelial cell tube formation assays in p62 knockdown group at 3 h (the second experiment pictures, repeat the second time)
Click here for additional data file.
Raw data exported from endothelial cell tube formation assays in p62 knockdown group at 3 h (the second experiment pictures, repeat the first time)
Click here for additional data file.
Raw data exported from endothelial cell tube formation assays in p62 knockdown group at 3 h (the third experiment pictures, repeat the second time)
Click here for additional data file.
Raw data exported from endothelial cell tube formation assays in U-937 at 3 h (the first experiment data, repeat second time)
Click here for additional data file.
Raw data exported from endothelial cell tube formation assays in U-937 at 3 h (the third experiment data, repeat the first time)
Click here for additional data file.
Raw data exported from endothelial cell tube formation assays in control group at 6 h (the first experiment data, repeat the first time)
Click here for additional data file.
Raw data exported from endothelial cell tube formation assays in U-937 at 3 h (the second experiment pictures, repeat the first time)
Click here for additional data file.
Raw data exported from endothelial cell tube formation assays in U-937 at 3 h (the first experiment pictures, repeat the second time)
Click here for additional data file.
Raw data exported from endothelial cell tube formation assays in HUVEC at 6 h (the first experiment pictures, repeat the first time)
Click here for additional data file.
Raw data exported from endothelial cell tube formation assays in HUVEC at 6 h (the second experiment pictures, repeat the fifth time)
Click here for additional data file.
Raw data exported from endothelial cell tube formation assays in HUVEC at 6 h (the third experiment pictures, repeat the first time)
Click here for additional data file.
Raw data exported from endothelial cell tube formation assays from U-937 exosomes at 6 h (the first experiment data, repeat the first time)
Click here for additional data file.
Raw data exported from endothelial cell tube formation assays from U-937 exosomes at 6 h (the third experiment data, repeat the second time)
Click here for additional data file.
Raw data exported from endothelial cell tube formation assays in HUVEC at 6 h (the second experiment pictures, repeat the second time)
Click here for additional data file.
Raw data exported from endothelial cell tube formation assays in HUVEC at 6 h (the second experiment pictures, repeat the third time)
Click here for additional data file.
Raw data exported from endothelial cell tube formation assays in HUVEC at 6 h (the second experiment pictures, repeat the first time)
Click here for additional data file.
Raw data exported from endothelial cell tube formation assays in HUVEC at 6 h (the third experiment pictures, repeat the third time)
Click here for additional data file.
Raw data exported from endothelial cell tube formation assays from control group exosomes at 6 h (the first experiment pictures, repeat the first time)
Click here for additional data file.
Raw data exported from endothelial cell tube formation assays from control group exosomes at 6 h (the first experiment pictures, repeat the third time)
Click here for additional data file.
Raw data exported from endothelial cell tube formation assays from control group exosomes at 6 h (the first experiment pictures, repeat the second time)
Click here for additional data file.
Raw data exported from endothelial cell tube formation assays from control group exosomes at 6 h (the third experiment pictures, repeat the second time)
Click here for additional data file.
Raw data exported from endothelial cell tube formation assays from control group exosomes at 6 h (the third experiment pictures, repeat the first time)
Click here for additional data file.
Raw data exported from endothelial cell tube formation assays from control group exosomes at 6 h (the second experiment pictures, repeat the first time)
Click here for additional data file.
Raw data exported from endothelial cell tube formation assays from p62 knockdown group exosomes at 6 h (the first experiment pictures, repeat the first time)
Click here for additional data file.
Raw data exported from endothelial cell tube formation assays from p62 knockdown group exosomes at 6 h (the third experiment pictures, repeat the first time)
Click here for additional data file.
Raw data exported from endothelial cell tube formation assays from p62 knockdown group exosomes at 6 h (the second experiment pictures, repeat the first time)
Click here for additional data file.
Raw data exported from endothelial cell tube formation assays from p62 knockdown group exosomes at 6 h (the second experiment pictures, repeat the first time)
Click here for additional data file.
Raw data exported from endothelial cell tube formation assays from p62 knockdown group exosomes at 6 h (the third experiment pictures, repeat the first time)
Click here for additional data file.
Raw data exported from endothelial cell tube formation assays from p62 knockdown group exosomes at 6 h (the third experiment pictures, repeat the third time)
Click here for additional data file.
Raw data exported from endothelial cell tube formation assays from p62 knockdown group exosomes at 6 h (the third experiment pictures, repeat the fourth time)
Click here for additional data file.
Raw data exported from endothelial cell tube formation assays from HUVEC exosomes at 6 h (the second experiment data, repeat the second time)
Click here for additional data file.
Raw data exported from endothelial cell tube formation assays from p62 knockdown group exosomes at 6 h (the fourth experiment pictures, repeat the second time)
Click here for additional data file.
Raw data exported from endothelial cell tube formation assays from p62 knockdown group exosomes at 6 h (the fourth experiment pictures, repeat the first time)
Click here for additional data file.
Raw data exported from endothelial cell tube formation assays from U-937 exosomes at 6 h (the first experiment pictures, repeat the second time)
Click here for additional data file.
Raw data exported from endothelial cell tube formation assays from U-937 exosomes at 6 h (the first experiment pictures, repeat the second time)
Click here for additional data file.
Raw data exported from endothelial cell tube formation assays from p62 knockdown group exosomes at 6 h (the fourth experiment pictures, repeat the third time)
Click here for additional data file.
Raw data exported from endothelial cell tube formation assays from U-937 exosomes at 6 h (the first experiment pictures, repeat the first time)
Click here for additional data file.
Raw data exported from endothelial cell tube formation assays from U-937 exosomes at 6 h (the second experiment pictures, repeat the second time)
Click here for additional data file.
Raw data exported from endothelial cell tube formation assays from U-937 exosomes at 6 h (the second experiment pictures, repeat the first time)
Click here for additional data file.
Raw data exported from endothelial cell tube formation assays from U-937 exosomes at 6 h (the second experiment pictures, repeat the first time)
Click here for additional data file.
Raw data exported from endothelial cell tube formation assays from U-937 exosomes at 6 h (the secnd experiment pictures, repeat the second time)
Click here for additional data file.
Raw data exported from endothelial cell tube formation assays from U-937 exosomes at 6 h (the third experiment pictures, repeat the second time)
Click here for additional data file.
Raw data exported from endothelial cell tube formation assays in HUVEC at 4 h using 20x microscopic (the fourth experiment pictures, repeat the second time)
Click here for additional data file.
Raw data exported from endothelial cell tube formation assays from control group exosomes at 4 h using 20x microscopic
Click here for additional data file.
Raw data exported from endothelial cell tube formation assays from control group exosomes at 4 h using 10x microscopic
Click here for additional data file.
Raw data exported from endothelial cell tube formation assays from p62 knockdown group exosomes at 4h using 10x microscopic
Click here for additional data file.
Raw data exported from endothelial cell tube formation assays from p62 knockdown group exosomes at 4h using 40x microscopic
Click here for additional data file.
Raw data exported from endothelial cell tube formation assays from p62 knockdown group exosomes at 4h using 20x microscopic
Click here for additional data file.
Raw data exported from endothelial cell tube formation assays from control group exosomes at 4 h using 40x microscopic
Click here for additional data file.
Raw data exported from endothelial cell tube formation assays from U-937 group exosomes at 4 h using 20x microscopic
Click here for additional data file.
Raw data exported from endothelial cell tube formation assays in HUVEC at 3 h using 10x microscopic
Click here for additional data file.
Raw data exported from endothelial cell tube formation assays in HUVEC at 3 h using 40x microscopic
Click here for additional data file.
Raw data exported from endothelial cell tube formation assays from U-937 group exosomes at 4 h using 40x microscopic
Click here for additional data file.
Raw data exported from endothelial cell tube formation assays in HUVEC at 4 h using 20x microscopic
Click here for additional data file.
Raw data exported from endothelial cell tube formation assays in HUVEC at 3 h using 20x microscopic
Click here for additional data file.
Raw data exported from endothelial cell tube formation assays from control group exosomes at 4 h using 10x microscopic
Click here for additional data file.
Raw data exported from endothelial cell tube formation assays from control group exosomes at 4 h using 20x microscopic
Click here for additional data file.
Raw data exported from endothelial cell tube formation assays from control group exosomes at 4 h using 40x microscopic
Click here for additional data file.
Raw data exported from endothelial cell tube formation assays from p62 knockdown group exosomes at 4h using 40x microscopic
Click here for additional data file.
Raw data exported from endothelial cell tube formation assays from p62 knockdown group exosomes at 4h using 10x microscopic
Click here for additional data file.
Raw data exported from endothelial cell tube formation assays from p62 knockdown group exosomes at 4h using 20x microscopic
Click here for additional data file.
Raw data exported from endothelial cell tube formation assays from U-937 group exosomes at 4 h using 10x microscopic
Click here for additional data file.
Raw data exported from endothelial cell tube formation assays in HUVEC at 4 h using 10x microscopic
Click here for additional data file.
Raw data exported from endothelial cell tube formation assays from U-937 group exosomes at 4 h using 20x microscopic
Click here for additional data file.
Raw data exported from endothelial cell tube formation assays in HUVEC at 4 h (repeat the first time)
Click here for additional data file.
Raw data exported from endothelial cell tube formation assays in HUVEC at 4 h using 40x microscopic (repeat the first time)
Click here for additional data file.
Raw data exported from endothelial cell tube formation assay in HUVEC at 4 h using 20x microscopic (repeat the first time)
Click here for additional data file.
Raw data exported from endothelial cell tube formation assays from control group exosomes at 4 h using 10x microscopic
Click here for additional data file.
Raw data exported from endothelial cell tube formation assays from control group exosomes at 4 h using 20x microscopic
Click here for additional data file.
Raw data exported from endothelial cell tube formation assays from p62 knockdown group exosomes at 4h using 10x microscopic
Click here for additional data file.
Raw data exported from endothelial cell tube formation assays from control group exosomes at 4 h using 40x microscopic
Click here for additional data file.
Raw data exported from endothelial cell tube formation assays from p62 knockdown group exosomes at 4h using 40x microscopic
Click here for additional data file.
Raw data exported from endothelial cell tube formation assays from p62 knockdown group exosomes at 4h using 20x microscopic
Click here for additional data file.
Raw data exported from endothelial cell tube formation assays from U-937 group exosomes at 4 h using 10x microscopic
Click here for additional data file.
Raw data exported from microarray analysis
Click here for additional data file.
Raw data exported from microarray analysis
Click here for additional data file.
Raw data exported from endothelial cell tube formation assays in HUVEC at 4 h using 40x microscopic
Click here for additional data file.
Raw data exported from endothelial cell tube formation assays from U-937 group exosomes at 4 h using 20x microscopic
Click here for additional data file.
Raw data exported from endothelial cell tube formation assays in HUVEC at 4 h using 10x microscopic
Click here for additional data file.
Raw data exported from endothelial cell tube formation assays from U-937 group exosomes at 4 h using 40x microscopic
Click here for additional data file.
Miame Checklist
Click here for additional data file.
Additional Information and Declarations
Competing Interests
The authors declare there are no competing interests.
Author Contributions
Chuan Li conceived and designed the experiments, performed the experiments, prepared figures and/or tables, authored or reviewed drafts of the article, and approved the final draft.
Xinyi Long conceived and designed the experiments, performed the experiments, prepared figures and/or tables, and approved the final draft.
Peiqi Liang analyzed the data, prepared figures and/or tables, and approved the final draft.
Zhuogang Liu conceived and designed the experiments, analyzed the data, prepared figures and/or tables, authored or reviewed drafts of the article, and approved the final draft.
Chen Wang analyzed the data, prepared figures and/or tables, and approved the final draft.
Rong Hu conceived and designed the experiments, prepared figures and/or tables, authored or reviewed drafts of the article, and approved the final draft.
Microarray Data Deposition
The following information was supplied regarding the deposition of microarray data:
The data is available at GEO: GSE192628 .
https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE192628 .
Data Availability
The following information was supplied regarding data availability:
The data are available in the Supplementary Files .
References
Agarwal et al. (2015) Agarwal V Bell GW Nam JW Bartel DP 2015 Predicting effective microRNA target sites in mammalian mRNAs Elife 4 e05005 10.7554/eLife.05005 PMC4532895 26267216
Aslan et al. (2019) Aslan C Maralbashi S Salari F Kahroba H Sigaroodi F Kazemi T Kharaziha P 2019 Tumor-derived exosomes: implication in angiogenesis and antiangiogenesis cancer therapy Journal of Cellular Physiology 234 16885 16903 10.1002/jcp.28374 30793767
Burnett, Wetzler & Lowenberg (2011) Burnett A Wetzler M Lowenberg B 2011 Therapeutic advances in acute myeloid leukemia Journal of Clinical Oncology 29 487 494 10.1200/JCO.2010.30.1820 21220605
Chen & Wang (2020) Chen Y Wang X 2020 miRDB: an online database for prediction of functional microRNA targets Nucleic Acids Research 48 D127 D131 10.1093/nar/gkz757 31504780 PMC6943051
De Kouchkovsky & Abdul-Hay (2016) De Kouchkovsky I Abdul-Hay M 2016 Acute myeloid leukemia: a comprehensive review and 2016 update Blood Cancer Journal 6 e441 10.1038/bcj.2016.50 27367478 PMC5030376
Haouas (2014) Haouas H 2014 Angiogenesis and acute myeloid leukemia Hematology 19 311 323 10.1179/1607845413Y.0000000139 24192539
Hornick et al. (2016) Hornick NI Doron B Abdelhamed S Huan J Harrington CA Shen R Cambronne XA Chakkaramakkil Verghese S Kurre P 2016 AML suppresses hematopoiesis by releasing exosomes that contain microRNAs targeting c-MYB Science Signaling 9 ra88 10.1126/scisignal.aaf2797 27601730
Ichimura et al. (2008) Ichimura Y Kumanomidou T Sou YS Mizushima T Ezaki J Ueno T Kominami E Yamane T Tanaka K Komatsu M 2008 Structural basis for sorting mechanism of p62 in selective autophagy Journal of Biological Chemistry 283 22847 22857 10.1074/jbc.M802182200 18524774
Jia et al. (2018) Jia W Wu W Yang D Xiao C Huang M Long F Su Z Qin M Liu X Zhu YZ 2018 GATA4 regulates angiogenesis and persistence of inflammation in rheumatoid arthritis Cell Death & Disease 9 503 10.1038/s41419-018-0570-5 29717129 PMC5931571
Komatsu, Kageyama & Ichimura (2012) Komatsu M Kageyama S Ichimura Y 2012 p62/SQSTM1/A170: physiology and pathology Pharmacological Research 66 457 462 10.1016/j.phrs.2012.07.004 22841931
Le Ber et al. (2013) Le Ber I Camuzat A Guerreiro R Bouya-Ahmed K Bras J Nicolas G Gabelle A Didic M De Septenville A Millecamps S Lenglet T Latouche M Kabashi E Campion D Hannequin D Hardy J Brice A French C Genetic Research Network on FF-A 2013 SQSTM1 mutations in French patients with frontotemporal dementia or frontotemporal dementia with amyotrophic lateral sclerosis JAMA Neurology 70 1403 1410 10.1001/jamaneurol.2013.3849 24042580 PMC4199096
Li et al. (2016) Li HS Jin J Liang X Matatall KA Ma Y Zhang H Ullrich SE King KY Sun SC Watowich SS 2016 Loss of c-Kit and bone marrow failure upon conditional removal of the GATA-2 C-terminal zinc finger domain in adult mice European Journal of Haematology 97 261 270 10.1111/ejh.12719 26660446 PMC5680037
Lin et al. (2019) Lin B Zhao K Yang D Bai D Liao Y Zhou Y Yu Z Yu X Guo Q Lu N 2019 Wogonoside impedes the progression of acute myeloid leukemia through inhibiting bone marrow angiogenesis Journal of Cellular Physiology 234 1913 1924 10.1002/jcp.27067 30105796
Liu et al. (2016) Liu WJ Ye L Huang WF Guo LJ Xu ZG Wu HL Yang C Liu HF 2016 p62 links the autophagy pathway and the ubiqutin-proteasome system upon ubiquitinated protein degradation Cellular & Molecular Biology Letters 21 29 10.1186/s11658-016-0031-z 28536631 PMC5415757
Myeku & Figueiredo-Pereira (2011) Myeku N Figueiredo-Pereira ME 2011 Dynamics of the degradation of ubiquitinated proteins by proteasomes and autophagy: association with sequestosome 1/p62 Journal of Biological Chemistry 286 22426 22440 10.1074/jbc.M110.149252 21536669 PMC3121389
Nguyen et al. (2017) Nguyen EV Huhtinen K Goo YA Kaipio K Andersson N Rantanen V Hynninen J Lahesmaa R Carpen O Goodlett DR 2017 Hyper-phosphorylation of sequestosome-1 distinguishes resistance to cisplatin in patient derived high grade serous ovarian cancer cells Molecular & Cellular Proteomics 16 1377 1392 10.1074/mcp.M116.058321 28455291 PMC5500768
Nguyen et al. (2019) Nguyen TD Shaid S Vakhrusheva O Koschade SE Klann K Tholken M Baker F Zhang J Oellerich T Surun D Derlet A Haberbosch I Eimer S Osiewacz HD Behrends C Munch C Dikic I Brandts CH 2019 Loss of the selective autophagy receptor p62 impairs murine myeloid leukemia progression and mitophagy Blood 133 168 179 10.1182/blood-2018-02-833475 30498063
Ohyashiki, Umezu & Ohyashiki (2016) Ohyashiki JH Umezu T Ohyashiki K 2016 Exosomes promote bone marrow angiogenesis in hematologic neoplasia: the role of hypoxia Current Opinion in Hematology 23 268 273 10.1097/MOH.0000000000000235 26866730
Pankiv et al. (2007) Pankiv S Clausen TH Lamark T Brech A Bruun JA Outzen H Overvatn A Bjorkoy G Johansen T 2007 p62/SQSTM1 binds directly to Atg8/LC3 to facilitate degradation of ubiquitinated protein aggregates by autophagy Journal of Biological Chemistry 282 24131 24145 10.1074/jbc.M702824200 17580304
Patel et al. (2012) Patel JP Gonen M Figueroa ME Fernandez H Sun Z Racevskis J Van Vlierberghe P Dolgalev I Thomas S Aminova O Huberman K Cheng J Viale A Socci ND Heguy A Cherry A Vance G Higgins RR Ketterling RP Gallagher RE Litzow M van den Brink MR Lazarus HM Rowe JM Luger S Ferrando A Paietta E Tallman MS Melnick A Abdel-Wahab O Levine RL 2012 Prognostic relevance of integrated genetic profiling in acute myeloid leukemia New England Journal of Medicine 366 1079 1089 10.1056/NEJMoa1112304 22417203 PMC3545649
Saito et al. (2016) Saito T Ichimura Y Taguchi K Suzuki T Mizushima T Takagi K Hirose Y Nagahashi M Iso T Fukutomi T Ohishi M Endo K Uemura T Nishito Y Okuda S Obata M Kouno T Imamura R Tada Y Obata R Yasuda D Takahashi K Fujimura T Pi J Lee MS Ueno T Ohe T Mashino T Wakai T Kojima H Okabe T Nagano T Motohashi H Waguri S Soga T Yamamoto M Tanaka K Komatsu M 2016 p62/Sqstm1 promotes malignancy of HCV-positive hepatocellular carcinoma through Nrf2-dependent metabolic reprogramming Nature Communications 7 12030 10.1038/ncomms12030 PMC4931237 27345495
Short, Rytting & Cortes (2018) Short NJ Rytting ME Cortes JE 2018 Acute myeloid leukaemia Lancet 392 593 606 10.1016/S0140-6736(18)31041-9 30078459 PMC10230947
Skog et al. (2008) Skog J Wurdinger T Rijn Svan Meijer DH Gainche L Sena-Esteves M Curry Jr WT Carter BS Krichevsky AM Breakefield XO 2008 Glioblastoma microvesicles transport RNA and proteins that promote tumour growth and provide diagnostic biomarkers Nature Cell Biology 10 1470 1476 10.1038/ncb1800 19011622 PMC3423894
Staudt et al. (2018) Staudt D Murray HC McLachlan T Alvaro F Enjeti AK Verrills NM Dun MD 2018 Targeting oncogenic signaling in mutant FLT3 acute myeloid leukemia: the path to least resistance International Journal of Molecular Sciences 19 10 3198 10.3390/ijms19103198 PMC6214138 30332834
Sun et al. (2010) Sun HY Wei SP Xu RC Xu PX Zhang WC 2010 Sphingosine-1-phosphate induces human endothelial VEGF and MMP-2 production via transcription factor ZNF580: novel insights into angiogenesis Biochemical and Biophysical Research Communications 395 361 366 10.1016/j.bbrc.2010.04.019 20382120
Trocoli et al. (2014) Trocoli A Bensadoun P Richard E Labrunie G Merhi F Schläfli AM Brigger D Souquere SPG Pasquet JM Soubeyran P Reiffers J Ségal-Bendirdjian E Tschan MP Djavaheri-Mergny M 2014 p62/SQSTM1 upregulation constitutes a survival mechanism that occurs during granulocytic differentiation of acute myeloid leukemia cells Cell Death & Differentiation 21 1852 1861 10.1038/cdd.2014.102 25034783 PMC4227143
Wang et al. (2019) Wang B Wang X Hou D Huang Q Zhan W Chen C Liu J You R Xie J Chen P Huang H 2019 Exosomes derived from acute myeloid leukemia cells promote chemoresistance by enhancing glycolysis-mediated vascular remodeling Journal of Cellular Physiology 234 10602 10614 10.1002/jcp.27735 30417360
Xie et al. (2014) Xie M Lu C Wang J McLellan MD Johnson KJ Wendl MC McMichael JF Schmidt HK Yellapantula V Miller CA Ozenberger BA Welch JS Link DC Walter MJ Mardis ER Dipersio JF Chen F Wilson RK Ley TJ Ding L 2014 Age-related mutations associated with clonal hematopoietic expansion and malignancies Nature Medicine 20 1472 1478 10.1038/nm.3733 PMC4313872 25326804